Redo-TAVR: Essential Concepts, Updated Data and Current Gaps in Evidence.

ABSTRACT: Within the last two decades, transcatheter aortic valve replacement (TAVR) has transformed the treatment strategy for symptomatic severe aortic stenosis (AS), representing a less invasive alternative to traditional open-chest surgery. With time, advances in device features, imaging planning, and implantation techniques have contributed to an improvement in safety as well as a reduction in procedural complications. This has led to the expansion of TAVR to lower-risk patients, where TAVR has shown favorable outcomes compared to surgical aortic valve replacement (SAVR). As TAVR expands to younger and lower-risk patients with longer life expectancies, the need for reintervention for failing transcatheter heart valves is expected to increase. Redo-TAVR has gained increasing relevance in the lif

SUBMITTER: Galhardo A 

PROVIDER: S-EPMC10381270 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature